ADMS - アダマス・ファ―マシュ―ティカルズ (Adamas Pharmaceuticals Inc.)


   FDA OKs Merck KGaA's MS med Mavenclad  2019-03-30
The FDA approves Merck KGaA ( OTCPK:MKGAY ) unit EMD Serono's Mavenclad (cladribine) tablets for the treatment of relapsing forms of multiple sclerosis (MS). More news on: Merck KGaA ADR, Celgene Corporation, Roche Holding AG, Healthcare stocks news, Read more …
   Adamas Knife Continues To Fall As Value Continues To Rise  2018-12-26
Adamas Pharmaceuticals, Inc. ( ADMS ) has had a volatile 2018 experiencing all-time highs and lows. I recently published an article on Adamas reviewing the results of the company's 3rd quarter earnings report and subsequent demolition of the share price. In that article, I categorized ADMS…